Evidence map›Paper›PMID 32451648›Full record

ArticleInternational journal of colorectal disease2020

The prognostic value of organ/space surgical site infection in stage I colorectal cancer recurrence.

Shintaro Akabane, Hiroyuki Egi, Yuji Takakura, Haruki Sada, Masatoshi Kochi, Kazuhiro Taguchi, Ikki Nakashima, Yusuke Sumi, Koki Sato, Hisaaki Yoshinaka and 2 more

Abstract read
PubMed Publisher
In one paragraph

Article in International journal of colorectal disease, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.3field-weighted citation impact, top 43% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 1 country.

Shintaro AkabaneDepartment of Gastroenterological and Transplant Surgery, Graduate School of Biomedical & Health Science, Hiroshima University, 1-2-3, Kasumi, Minami-ku, Hiroshima, 734-8551, Japan.
Hiroyuki EgiDepartment of Gastroenterological and Transplant Surgery, Graduate School of Biomedical & Health Science, Hiroshima University, 1-2-3, Kasumi, Minami-ku, Hiroshima, 734-8551, Japan. hiroegi@yahoo.co.jp.
Yuji TakakuraDepartment of Gastroenterological and Transplant Surgery, Graduate School of Biomedical & Health Science, Hiroshima University, 1-2-3, Kasumi, Minami-ku, Hiroshima, 734-8551, Japan.
Haruki SadaDepartment of Surgery, National Hospital Organization, Kure Medical Center and Chugoku Cancer Center, Kure-City, Hiroshima, Japan.
Masatoshi KochiDepartment of Gastroenterological and Transplant Surgery, Graduate School of Biomedical & Health Science, Hiroshima University, 1-2-3, Kasumi, Minami-ku, Hiroshima, 734-8551, Japan.
Kazuhiro TaguchiDepartment of Gastroenterological and Transplant Surgery, Graduate School of Biomedical & Health Science, Hiroshima University, 1-2-3, Kasumi, Minami-ku, Hiroshima, 734-8551, Japan.
Ikki NakashimaDepartment of Gastroenterological and Transplant Surgery, Graduate School of Biomedical & Health Science, Hiroshima University, 1-2-3, Kasumi, Minami-ku, Hiroshima, 734-8551, Japan.
Yusuke SumiDepartment of Gastroenterological and Transplant Surgery, Graduate School of Biomedical & Health Science, Hiroshima University, 1-2-3, Kasumi, Minami-ku, Hiroshima, 734-8551, Japan.
Koki SatoDepartment of Gastroenterological and Transplant Surgery, Graduate School of Biomedical & Health Science, Hiroshima University, 1-2-3, Kasumi, Minami-ku, Hiroshima, 734-8551, Japan.
Hisaaki YoshinakaDepartment of Gastroenterological and Transplant Surgery, Graduate School of Biomedical & Health Science, Hiroshima University, 1-2-3, Kasumi, Minami-ku, Hiroshima, 734-8551, Japan.
Minoru HattoriCenter for Medical Education School of Medicine, Hiroshima University, Higashihiroshima, Hiroshima, Japan.
Hideki OhdanDepartment of Gastroenterological and Transplant Surgery, Graduate School of Biomedical & Health Science, Hiroshima University, 1-2-3, Kasumi, Minami-ku, Hiroshima, 734-8551, Japan.
Hiroshima University · JPKure Medical Center · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeEvidence on risk factors for postoperative recurrence in patients with colorectal cancer (CRC) confined to pathological stage I is limited. Therefore, this study aimed to identify the risk factors for recurrence in patients with stage I CRC.

methodsData on clinicopathological factors and blood tests of patients diagnosed with pathological stage I CRC at Hiroshima University Hospital between April 1, 2010, and December 31, 2018, were retrospectively obtained. The statistical significance between the clinical factors and postoperative recurrence was also investigated.

resultsA total of 244 patients were included. The median observation period was 45 months. There were 17 patients (6.6%) with a postoperative recurrence (8 local and 9 distant recurrences). In the log-lank test, rectal cancer (p = 0.004), pT2 (p = 0.020) and organ/space surgical site infection (SSI) (p = 0.008) were significantly associated with postoperative recurrence. In a multivariate analysis, rectal cancer (hazard ratio [HR] 3.678, 95% confidence interval [CI] 1.184-11.425, p = 0.024) and organ/space SSI (HR 3.137, 95% CI 1.013-9.713, p = 0.047) were independently associated with a higher recurrence rate. Among 18 patients with organ/space SSI, 4 recurrences occurred, all of which were distant metastases.

conclusionOrgan/space SSI significantly affects the postoperative recurrence in patients with stage I CRC.

Indexed as

Colorectal NeoplasmsSurgical Wound InfectionHumansNeoplasm Recurrence, LocalPrognosisRetrospective StudiesRisk FactorsColorectal cancerOrgan/space surgical site infectionPostoperative recurrenceStage I

Identifiers

PMID32451648
OpenAlexW3032526697

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.